Clinical Trial Update: A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients. [Phase 4]

View source ↗

Summary

Phase IV, open-label, single-arm study evaluating the pharmacokinetics and pharmacodynamics of the antiretroviral combination rilpivirine plus ritonavir-boosted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)
• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 4 | Status: COMPLETED